Compete with Crescent Diagnostics?
Brief our analysts.
Get in front of tech buyers.
Compare Crescent Diagnostics to Competitors
Integrative Diagnostics is a early cancer detection company founded by Leroy Hood.
3PrimiR is researching how mutations in micro RNA molecules can be used in cancer diagnostics.
MicroPhage's mission is to be a worldwide pioneer in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility/resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics.
Oncose is a post-genomics glyco-proteomics company developing in-vitro diagnostics tests for early cancer detection. The Company believes its blood serum tests based on cancer specific glycoprotein tumor markers, will revolutionize the field of early cancer diagnostics.
Columbia BioSystems Inc. is a company engaged in molecular Nano-diagnostics using Molecularly Imprinted Polymers (MIPs) for the rapid detection of pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA) , Anthrax, HIV, and Trypanosomiasis (sleeping sickness). The company uses MIPs to bind to proteins and, upon binding, change color thereby signaling the presence of the bacteria, virus or parasite.
Litholink offers metabolic evaluations for kidney stone formers.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.